242 related articles for article (PubMed ID: 28106465)
1. Evaluation of
Wang J; Zhang R
Br J Radiol; 2017 Mar; 90(1071):20160836. PubMed ID: 28106465
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Piga M; Cocco MC; Serra A; Boi F; Loy M; Mariotti S
Eur J Endocrinol; 2008 Oct; 159(4):423-9. PubMed ID: 18603573
[TBL] [Abstract][Full Text] [Related]
3. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone-induced thyrotoxicosis. A review.
Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
[TBL] [Abstract][Full Text] [Related]
5. Approach to the patient with amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
[TBL] [Abstract][Full Text] [Related]
6. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
7. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosis.
Pattison DA; Westcott J; Lichtenstein M; Toh HB; Gunawardana D; Better N; Forehan S; Sivaratnam D
Nucl Med Commun; 2015 Apr; 36(4):356-62. PubMed ID: 25569865
[TBL] [Abstract][Full Text] [Related]
9. [Amiodarone treatment and thyroid disorders].
Łacka K; Fraczek MM
Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone-Induced Thyrotoxicosis: Differential Diagnosis Using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR).
Censi S; Bodanza V; Manso J; Gusella S; Watutantrige-Fernando S; Cavedon E; Barollo S; Bertazza L; Cecchin D; Mian C
Clin Nucl Med; 2018 Sep; 43(9):655-662. PubMed ID: 30036255
[TBL] [Abstract][Full Text] [Related]
11. Radioactive iodine in the treatment of type-2 amiodarone-induced thyrotoxicosis.
Gursoy A; Tutuncu NB; Gencoglu A; Anil C; Demirer AN; Demirag NG
J Natl Med Assoc; 2008 Jun; 100(6):716-9. PubMed ID: 18595575
[TBL] [Abstract][Full Text] [Related]
12. Importance of (99)mTc-sestaMIBI thyroid scan in a case of amiodarone-induced thyrotoxicosis.
Souto SB; Fernandes H; Matos MJ; Braga DC; Pereira J; Carvalho D
Arq Bras Endocrinol Metabol; 2011 Oct; 55(7):486-9. PubMed ID: 22147098
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association.
Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response.
Wong R; Cheung W; Stockigt JR; Topliss DJ
Intern Med J; 2003; 33(9-10):420-6. PubMed ID: 14511194
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography.
Eaton SE; Euinton HA; Newman CM; Weetman AP; Bennet WM
Clin Endocrinol (Oxf); 2002 Jan; 56(1):33-8. PubMed ID: 11849244
[TBL] [Abstract][Full Text] [Related]
16. 99m Tc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis : Functional Imaging-Histopathologic Correlation.
Wang R; Better N; Sivaratnam D; Westcott J; Forehan S; Christie M; Pattison DA; Fourlanos S
Clin Nucl Med; 2022 Sep; 47(9):e582-e584. PubMed ID: 35835112
[TBL] [Abstract][Full Text] [Related]
17. 99mTc Sestamibi Thyroid Scan in Amiodarone-Induced Thyrotoxicosis Type I.
Patel NR; Tamara LA; Lee H
Clin Nucl Med; 2016 Jul; 41(7):566-7. PubMed ID: 27163459
[TBL] [Abstract][Full Text] [Related]
18. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
Irimie A; Piciu D
Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
[TBL] [Abstract][Full Text] [Related]
19. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy.
Bogazzi F; Bartalena L; Dell'Unto E; Tomisti L; Rossi G; Pepe P; Tanda ML; Grasso L; Macchia E; Aghini-Lombardi F; Pinchera A; Martino E
Clin Endocrinol (Oxf); 2007 Oct; 67(4):533-7. PubMed ID: 17561980
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD
Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
